A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol
Launched by PFIZER'S UPJOHN HAS MERGED WITH MYLAN TO FORM VIATRIS INC. · Mar 25, 2008
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with high cholesterol eligible for treatment with baseline LDL-C level of less than or equal to 220 mg/dL
- • Willingness to follow diet
- Exclusion Criteria:
- • Triglycerides less than or equal to 400 mg/dL
- • Hemoglobin A1c \>10%
About Pfizer's Upjohn Has Merged With Mylan To Form Viatris Inc.
Viatris Inc. is a global healthcare company formed from the merger of Pfizer's Upjohn division and Mylan, dedicated to providing access to high-quality medicines, including generics and specialty pharmaceuticals. With a strong commitment to innovation and patient-centric solutions, Viatris leverages a diverse portfolio and extensive global reach to address the evolving healthcare needs of patients worldwide. The company aims to create sustainable healthcare solutions by combining expertise in pharmaceutical development, manufacturing, and distribution, ultimately enhancing patient outcomes and improving overall health systems.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santiago, , Chile
Bogota, Cundinamarca, Colombia
São José Do Rio Preto, Sp, Brazil
Panama, , Panama
Belo Horizonte, Mg, Brazil
Curitiba, Pr, Brazil
Campinas, Sp, Brazil
Guadalajara, Jalisco, Mexico
Durango, , Mexico
Bogotá, Cundinamarca, Colombia
Guatemala, , Guatemala
Sao Paulo, Sp, Brazil
Porto Alegre, Rs, Brazil
Zapopan, Jalisco, Mexico
Chihuahua, , Mexico
Monterrey, Nuevo León, Mexico
Caracas, , Venezuela
Rio De Janeiro, Rj, Brazil
São Paulo, Sp, Brazil
São José, Sc, Brazil
Barranquilla, , Colombia
Bogotá, C/Marca, , Colombia
Cali, Valle, , Colombia
Quito, Pichincha / Ecuador, Ecuador
Dtto. Federal, Caracas, Venezuela
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials